| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.66▼ | 4.66▼ | 4.66▼ | 4.78▼ | 5.05▼ |
| MA10 | 4.65▲ | 4.67▼ | 4.69▼ | 4.77▼ | 5.08▼ |
| MA20 | 4.65▼ | 4.69▼ | 4.73▼ | 5.05▼ | 5.59▼ |
| MA50 | 4.67▼ | 4.74▼ | 4.77▼ | 5.12▼ | 4.86▼ |
| MA100 | 4.69▼ | 4.76▼ | 4.91▼ | 5.60▼ | 4.11▲ |
| MA200 | 4.74▼ | 4.94▼ | 5.10▼ | 5.20▼ | 3.46▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.001▼ | -0.007▼ | -0.030▼ | -0.149▼ |
| RSI | 47.110▼ | 39.789▼ | 40.597▼ | 40.362▼ | 42.997▼ |
| STOCH | 70.657 | 46.898 | 35.082 | 48.687 | 30.214 |
| WILL %R | -37.500 | -66.667 | -73.684 | -72.199 | -89.482▼ |
| CCI | 0.000 | -60.355 | -87.379 | -75.936 | -127.072▼ |
|
Monday, May 18, 2026 05:10 AM
Event will provide an overview of Lymphatic Malformations, the treatment landscape and the TARA-002 clinical programNEW YORK, May 18, 2026 ...
|
|
Friday, May 15, 2026 04:50 AM
TARA-002 demonstrates 72% complete response rate at any time, 67% complete response rate at the 6-month landmark and 55% complete response rate at the 12-month landmark in BCG-Naïve patients Favorable ...
|
|
Monday, April 27, 2026 09:06 AM
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/05/26 | 4.70 | 4.74 | 4.60 | 4.65 | 546,373 |
| 28/05/26 | 4.73 | 4.80 | 4.65 | 4.75 | 703,070 |
| 27/05/26 | 4.81 | 4.96 | 4.7037 | 4.76 | 695,917 |
| 26/05/26 | 5.00 | 5.005 | 4.625 | 4.80 | 825,566 |
| 22/05/26 | 4.99 | 5.03 | 4.82 | 4.92 | 1,124,302 |
| 21/05/26 | 4.67 | 5.09 | 4.67 | 4.97 | 2,510,757 |
| 20/05/26 | 4.41 | 4.77 | 4.41 | 4.76 | 701,326 |
| 19/05/26 | 4.64 | 4.66 | 4.315 | 4.34 | 496,064 |
| 18/05/26 | 5.10 | 5.16 | 4.49 | 4.60 | 1,019,074 |
| 15/05/26 | 5.13 | 5.205 | 5.04 | 5.10 | 1,122,891 |
|
|
||||
|
|
||||
|
|